Nonoperating Income (Expense) of Co-Diagnostics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Co-Diagnostics, Inc. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $39,568, a 107% decline year-over-year.
  • Co-Diagnostics, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $2,198,752, a 16% decline year-over-year.
  • Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2024 was $2,499,670, a 46% decline from 2023.
  • Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2023 was $4,595,678, a 43% decline from 2022.
  • Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2022 was $8,132,603.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Co-Diagnostics, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,198,752 $39,568 -$600,239 -107% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $2,798,991 $339,974 +$238,740 +236% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $2,560,251 $1,030,689 +$60,581 +6.2% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $2,499,670 $867,657 -$115,103 -12% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $2,614,773 $560,671 -$279,505 -33% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $2,894,278 $101,234 -$736,060 -88% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $3,630,338 $970,108 -$965,340 -50% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $4,595,678 $982,760 -$94,177 -8.7% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $4,689,855 $840,176 -$2,219,739 -73% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $6,909,594 $837,294 +$118,066 +16% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $6,791,528 $1,935,448 -$1,341,075 -41% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $8,132,603 $1,076,937 +$1,141,371 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $6,991,232 $3,059,915 +$3,113,476 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $3,877,756 $719,228 +$580,104 +417% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $3,297,652 $3,276,523 +$3,726,809 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $429,157 $64,434 +$152,178 +70% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $581,335 $53,561 -$832,110 -107% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $250,775 $139,124 -$157,608 -53% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $408,383 $450,286 -$467,042 -2787% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $875,425 $216,612 01 Oct 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $778,549 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $296,732 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $16,756 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1

Co-Diagnostics, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,499,670 -$2,096,008 -46% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $4,595,678 -$3,536,925 -43% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $8,132,603 +$8,561,760 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $429,157 -$1,304,582 -149% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $875,425 +$1,177,241 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 $301,816 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.